Adarza BioSystems Revenue and Competitors
Estimated Revenue & Valuation
- Adarza BioSystems's estimated annual revenue is currently $930k per year.
- Adarza BioSystems's estimated revenue per employee is $77,500
- Adarza BioSystems's total funding is $64.2M.
Employee Data
- Adarza BioSystems has 12 Employees.
- Adarza BioSystems grew their employee count by 9% last year.
Adarza BioSystems's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director Finance | Reveal Email/Phone |
Adarza BioSystems Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Adarza BioSystems?
The Arrayed Imaging Reflectometry (AIR) is a label-free platform technology that enables the simultaneous detection of hundreds of analytes in a single drop of fluid. Adarza delivers industry leading precision, accuracy, and robustness enabling highly multiplexed protein detection with high sensitivity and specificity. The companyￃﾢ￢ﾂﾬ￢ﾄﾢs unique technology is flexible, data-rich, and easy to use, providing the only solution that spans the entire companion diagnostic life cycle from discovery to clinic, in both high-throughput core facilities as well as point of care (POC). Much like the first gene-chips enabled multiplexed genomics analysis, Adarzaￃﾢ￢ﾂﾬ￢ﾄﾢs first-to-market high-multiplex and sensitivity antibody chips will fundamentally disrupt the field of proteomics research.
keywords:N/A
$64.2M
Total Funding
12
Number of Employees
$930k
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Adarza BioSystems News
Adarza BioSystems, Inc., a Rochester, N.Y. and St. Louis, Mo.-based developer and manufacturer of label-free biosensor assays and instruments servicing life science research, drug development and in vitro diagnostics customers, closed a $17M Series C financing. The round was led by 3×5 RiverVes ...
Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final ...
Adarza BioSystems, a West Henrietta, NY- and St. Peters, MO-based provider of label-free, multiplex assays, closed a $5m Series B financing. Backers included Cultivation Capital, Lewis and Clark Ventures and Siemens’ venture capital arm. The company intends to use the funds to expand productio ...
Other Companies in Maryland Heights
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.1M | 17 | -39% | N/A |
#2 | $3.3M | 17 | -15% | N/A |
#3 | $2.1M | 21 | 11% | N/A |
#4 | $4.4M | 22 | -48% | N/A |
#5 | $2.2M | 22 | -8% | N/A |